Labshake search
Citations for Akoya Biosciences :
1 - 40 of 40 citations for Recombinant Human ROR1 protein His tagged R PE labeled since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2023Quote: ... The probe was tagged to opal 570 dye from Akoya Biosciences (Marlborough ...
-
bioRxiv - Neuroscience 2023Quote: ... The Pvalb probe was tagged with Opal 650 reagent (Akoya #OP001005) and the mCherry probe was tagged with Opal 570 reagent (Akoya #OP001003).
-
bioRxiv - Neuroscience 2023Quote: ... and the mCherry probe was tagged with Opal 570 reagent (Akoya #OP001003).
-
bioRxiv - Immunology 2021Quote: ... labeled with selected Opal Fluorophore reagent (Akoya Bioscience) at dilution facto (1:1000 ...
-
bioRxiv - Neuroscience 2021Quote: ... fos mRNA was then tagged to the fluorophore fluorescein (1:1500; NEL741E001KT, Akoya Biosciences), and v1aR-mRNA was tagged to the fluorophore Cy5 (1:1500 ...
-
bioRxiv - Neuroscience 2021Quote: ... and v1aR-mRNA was tagged to the fluorophore Cy5 (1:1500; NEL745E001KT, Akoya Biosciences). Slides were then rinsed in TBS and stained with a fluorescent Nissl (1:500 ...
-
bioRxiv - Neuroscience 2023Quote: ... probes were amplified and fluorescently labeled with Opal dyes as follows: PROX1 was labeled with 1:500 Opal 520 (catalog no. FP1487001KT, Akoya Biosciences [AB]), LAMP5 was labeled with 1:500 Opal 690 (catalog no ...
-
bioRxiv - Neuroscience 2024Quote: ... mRNAs of interest were labeled with the following fluorophores (Akoya): Opal 520 (FP1487001KT) ...
-
bioRxiv - Neuroscience 2021Quote: ... the FITC-labeled probe was visualized using tyramide-FITC Plus (Akoya Biosciences ...
-
bioRxiv - Neuroscience 2022Quote: ... the FITC-labeled probe was visualized using tyramide-FITC Plus (Akoya Biosciences ...
-
bioRxiv - Immunology 2021Quote: ... Probes were fluorescently labeled with Opal™ 570 Reagent (Akoya Biosciences, FP1488001KT) and Opal™ 620 Reagent (Akoya Biosciences ...
-
bioRxiv - Neuroscience 2021Quote: ... was used to detect the Flu-labeled RNA probe by TSA-plus biotin (AKOYA Bioscience ...
-
bioRxiv - Cancer Biology 2024Quote: ... Signal for antibody complexes was labeled and visualized by their corresponding Opal Fluorophore Reagents (Akoya) by incubating the slides for 10 minutes ...
-
bioRxiv - Immunology 2024Quote: ... The data was then analyzed using R software and the phenoptrReports package (Akoya).
-
bioRxiv - Microbiology 2022Quote: Fluorescently labeled slides were imaged using a Vectra Polaris TM Quantitative Pathology Imaging System (Akoya Biosciences). Exposures for all Opal dyes on the Vectra were set based upon regions of interest with strong signal intensities to minimize exposure times and maximize the specificity of signal detected.
-
bioRxiv - Immunology 2021Quote: ... and Probe-Mm-Mki67-C3) were amplified and labeled with Opal 570 or Opal 620 (Akoya Biosciences) for each experiment ...
-
bioRxiv - Neuroscience 2023Quote: ... the FITC-labeled probe was visualized using tyramide-FITC Plus (1/50 dilution, 15-minute incubation, Akoya Biosciences). Following washes in TNT ...
-
bioRxiv - Neuroscience 2024Quote: ... was used to detect Flu-labeled RNA probes by a 1:70 TSA-plus biotin (#NEL749A001KT; AKOYA Bioscience), which was then visualized with streptavidin-AF488 (at a dilution of 1:250 ...
-
bioRxiv - Microbiology 2021Quote: Fluorescently labeled slides were imaged using either a Mantra 2.0TMor Vectra Polaris TM Quantitative Pathology Imaging System (Akoya Biosciences). To maximize signal-to-noise ratios ...
-
Resolution of SARS-CoV-2 infection in human lung tissues is driven by extravascular CD163+ monocytesbioRxiv - Immunology 2024Quote: Fluorescently labeled slides were imaged using either a Mantra 2.0TMor Vectra Polaris TM Quantitative Pathology Imaging System (Akoya Biosciences). To maximize signal-to-noise ratios ...
-
bioRxiv - Immunology 2024Quote: Fluorescent and chromogen labeled slides were imaged at 40X using a Vectra PolarisTM Quantitative Pathology Imaging System (Akoya Biosciences). For fluorescently labeled slides ...
-
bioRxiv - Pathology 2021Quote: Fluorescently labeled slides were imaged using a Mantra 2.0TM or Vectra PolarisTM Qunatitative Pathology Imaging System (Akoya Biosciences, Marlborough, MA). To maximize signal-to-noise ratios ...
-
bioRxiv - Developmental Biology 2023Quote: ... the DIG-labeled probes were amplified with the Cy3 TSA reagent included with the TSA Signal Amplification kit from Akoya Biosciences ...
-
bioRxiv - Pathology 2023Quote: ... secondary antibodies labeled with horseradish peroxidase (all with reduced cross-reactivity from Jackson-Immunoresearch) in combination with 7plex Opal system (Akoya) were used according to the manufacturer’s protocol ...
-
bioRxiv - Cancer Biology 2022Quote: ... anti-ER (Cell Marque, 249-R-15-ASR, clone: SP1, 1:70 dilution) with Opal 650 (Akoya Biosciences ...
-
bioRxiv - Developmental Biology 2023Quote: ... Fluorescent RNA in situ hybridization was done with DIG-labeled probes for white and yellow with TSA Plus Fluorescence Kits (Akoya Biosciences) and used for in situ hybridization to imaginal discs as described (Tian et al ...
-
bioRxiv - Neuroscience 2023Quote: ... After the described washes and blocking steps the DIG-labeled probes were visualized using tyramide-Cy3 Plus (1/75 dilution, 15-minute incubation, Akoya Biosciences). After washes in TNT ...
-
bioRxiv - Biochemistry 2022Quote: ... Probe remaining on the tissue sections was amplified and labeled with a single Opal 520 fluorophore at a dilution of 1:750 (OP-001001, Akoya Biosciences, Marlborough). After RNA labeling ...
-
bioRxiv - Immunology 2021Quote: ... protein blocking in Akoya Antibody Diluent/Block (Akoya biosciences, MA) took place for 10 minutes ...
-
bioRxiv - Developmental Biology 2021Quote: ... with probe for human TINAGL1(Advanced Cell Diagnostics #857221-C2) and OPAL 570 fluorophore (Akoya #FP1488001KT), following the manufacturer’s protocol.
-
bioRxiv - Genomics 2020Quote: ... and human retina background fluorescence slide was used to spectrally unmix images in InForm software (Akoya Biosciences) for visualization of each color.
-
bioRxiv - Cancer Biology 2023Quote: ... Protein blocking was performed using antibody diluent/blocking buffer (Akoya, ARD1001EA) for 10 minutes at room temperature ...
-
bioRxiv - Neuroscience 2023Quote: ... The probe combination used was human specific SCN9A (Cat 562251, ACD) paired with Cy3 (Cat NEL744001KT, Akoya Biosciences) and TACR1 (Cat 310701-3 ...
-
bioRxiv - Cell Biology 2023Quote: PhenoCycler-Fusion (PCF) on Human Tissues: All reagents in this section were purchased and used as received from Akoya Biosciences unless otherwise noted ...
-
bioRxiv - Immunology 2020Quote: We stained 5-µm-thick formalin-fixed paraffin-embedded sections from human xenograft tumors (UMSCC-1) using Opal multiplex kits (PerkinElmer/Akoya), for a panel of DAPI ...
-
bioRxiv - Genomics 2023Quote: Formalin fixed paraffin embedded human breast tissue was analyzed using COdetection by inDEXing (CODEX®/PhenoCycler - Akoya Biosciences, Marlborough, MA). The experiments were performed following manufacturer’s protocols ...
-
bioRxiv - Immunology 2022Quote: ... was stained with 6 protein markers (Figure 4A) and captured with PhenoImager® imaging system (Akoya Biosciences). Over 15,000 cell type annotations from 35 training set slides were used as a training set ...
-
bioRxiv - Systems Biology 2023Quote: ... Proximal protein biotinylation occurs with treatment of H2O2 and tyramide-biotin (TSA Biotin System, Akoya Bioscience NEL700A001KT), resulting in tyramide-biotin radicalization and covalent deposition onto proximal proteins ...
-
bioRxiv - Cancer Biology 2022Quote: ... tissue slides were exposed to multiple staining cycles each including a 30 minute incubation with a protein block (Akoya), 1 hour incubation with the respective primary antibody ...
-
bioRxiv - Cancer Biology 2022Quote: ... tissue slides were exposed to multiple staining cycles each including a 30 minute incubation with a protein block (Akoya), 1 hour incubation with the respective primary antibody ...